Search: onr:"swepub:oai:gup.ub.gu.se/326517" >
Leishmania infantum...
Leishmania infantum infection after visiting southern Spain in patients on biological treatment; an observational, longitudinal, cohort study
-
- Hammarström, Helena (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine
-
Moreno, J. (author)
-
Dotevall, L. (author)
-
show more...
-
- Calander, Ann-Marie, 1957 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning,Institute of Medicine, Department of Rheumatology and Inflammation Research
-
show less...
-
(creator_code:org_t)
- Elsevier BV, 2023
- 2023
- English.
-
In: Travel Medicine and Infectious Disease. - : Elsevier BV. - 1477-8939. ; 53
- Related links:
-
https://gup.ub.gu.se...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Background: Reports of leishmaniasis in immunosuppressed patients after visiting the Mediterranean Basin are becoming increasingly common. Still, awareness of the risk of infection and its clinical manifestations may be insufficient among healthcare professionals in the travellers' home countries.Methods: This observational, longitudinal study included 47 patients from Sweden with rheumatic disease and ongoing immunomodulatory treatment, who visited a rehabilitation centre in southern Spain where leishman-iasis is endemic. Patients were evaluated for clinical signs of leishmaniasis at baseline and after three years. Patients with leishmaniasis were followed for 4-5 years. The treatment outcome was assessed by clinical eval-uation and determination of the cell-mediated immunological response to Leishmania by a whole blood cytokine release assay.Results: Seven patients (15%) were diagnosed with leishmaniasis. The median time from exposure to the onset of symptoms was 3 [1-17] months. The median delay between the onset of symptoms and treatment start was 9 [1-12] months. All patients with leishmaniasis responded well to treatment. Only one patient had a relapse, which occurred within the first year.Conclusion: Healthcare professionals need to be aware of the increased risk of leishmaniasis for travellers who are immunosuppressed. Knowledge of the symptoms is crucial for a timely diagnosis and early treatment.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
Keyword
- Leishmaniasis
- Immunosuppression
- Rheumatic disease
- Biological
- treatment
- Tumour necrosis factor alpha inhibitor
- Travel medicine
- necrosis factor therapy
- of-the-literature
- cutaneous leishmaniasis
- visceral leishmaniasis
- challenge
- travelers
- outbreak
- Public
- Environmental & Occupational Health
- Infectious Diseases
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database